Class 4 drug alert – Ibuprofen tablets 400mg Crescent Pharma Ltd and Flamingo Pharma (UK) Ltd (UPDATED BATCHES)

20th February 2020

Ref: EL (20)A/10(U)

24 February 2020

A Class 4 drug alert has been issued by the Medicines & Healthcare products Regulatory Agency (MHRA).  Crescent Pharma Ltd and Flamingo Pharma (UK) Ltd have informed the MHRA that the Patient Information Leaflet (PIL) for specific batches of Ibuprofen tablets 400mg is incorrect

Further information can be found on the MHRA section on the GOV.UK website.

Produced by the NPA Pharmacy Services team February 2020